Home

Paul F. Lizzul

CIK 1711462 · Chief Medical Officer · last filed 2026-05-14

Paul F. Lizzul is a Chief Medical Officer who has filed 35 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for TRAX, was dated May 14, 2026. Across all open-market trades the lifetime net is −$745.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.98M

Companies

3

Total Filings

35

Lifetime Open-Market Net

-$745.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TRAX Chief Medical Officer 42,669 $41.85 $1.79M $0 2 2026-05-14
ANAB Chief Medical Officer 42,088 $52.11 $2.19M -$895.2K 20 2026-01-09
Sienna Biopharmaceuticals, Inc. (SNNA) Delisted Chief Medical Officer 207,045 — — $150.0K 6 2019-08-08

Recent Filings

35 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-05-14 TRAX Grant (A) — $0 EDGAR
2026-04-22 TRAX Grant (A) — $0 EDGAR
2026-01-09 ANAB Mixed +4,875 -$163.2K EDGAR
2026-01-09 ANAB Notice (144) −3,650 -$165.0K EDGAR
2026-01-08 ANAB Mixed +3,910 -$100.8K EDGAR
2026-01-08 ANAB Notice (144) −2,235 -$98.1K EDGAR
2026-01-06 ANAB Mixed +6,336 -$182.5K EDGAR
2026-01-06 ANAB Notice (144) −4,219 -$189.6K EDGAR
2025-12-23 ANAB Mixed — -$47.2K EDGAR
2025-12-22 ANAB Notice (144) −1,500 -$75.0K EDGAR
Showing 1–10 of 35
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.